Wegovy for Overweight Young Children: Novo Nordisk’s Obesity Drug Shows Effectiveness

기사 요약

Novo Nordisk Phase 3 STEP Young trial shows once-weekly semaglutide reduced BMI in 40.4% of children with obesity after 68 weeks.